GIS
26
3
VRSN
53
3
ILMN
32
-3
AMP
69
-3
DAL
80
-4
VRTX
46
2
VLO
40
-2
JPM
63
-4
EXC
54
-2
EL
20
3
HIG
67
4
HP
38
-2
PRU
57
-3
TRV
53
-3
IFF
53
2
APA
21
2
HRL
39
15
EQT
59
2
MDLZ
34
2
BA
52
2
GIS
26
3
VRSN
53
3
ILMN
32
-3
AMP
69
-3
DAL
80
-4
VRTX
46
2
VLO
40
-2
JPM
63
-4
EXC
54
-2
EL
20
3
HIG
67
4
HP
38
-2
PRU
57
-3
TRV
53
-3
IFF
53
2
APA
21
2
HRL
39
15
EQT
59
2
MDLZ
34
2
BA
52
2
Financhill
Back

Neurogene Vs. CEL-SCI Industry Stock Comparison

Sell
4

NGNE
Neurogene

Last Price:
15.45
Seasonality Move:
43.35%
Sell
40

CVM
CEL-SCI

Last Price:
0.61
Seasonality Move:
20.06%
Sell
4
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $15.33. The Score for NGNE is 4, which is 92% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
40
CEL-SCI (CVM) is a Sell

Is CEL-SCI a Buy, Sell or Hold?

  • The current CEL-SCI [CVM] share price is $0.63. The Score for CVM is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • CVM is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $15.33
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing selling pressure, which indicates risk of future bearish movement.

CVM Stock Price Chart

What is CEL-SCI's stock price today?

  • The CEL-SCI share price today is $0.63
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CVM is experiencing slight buying pressure.

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.5 Sell
Relative Strength Index (14 RSI): 26.19 Sell
Chaikin Money Flow: -759663 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (32.59 - 62.57) Sell
Bollinger Bands (100): (32.85 - 50.97) Sell

CVM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.1 Sell
Relative Strength Index (14 RSI): 30.33 Sell
Chaikin Money Flow: -30918 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.66 - 0.92) Sell
Bollinger Bands (100): (0.86 - 1.26) Sell

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 34.65 Sell
20-day SMA: 46.53 Sell
50-day SMA: 45.64 Sell
200-day SMA: 38.79 Sell
8-day EMA: 31.23 Sell
20-day EMA: 41.67 Sell
50-day EMA: 44.07 Sell
200-day EMA: 37.82 Sell

CVM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.63 Buy
20-day SMA: 0.76 Sell
50-day SMA: 0.94 Sell
200-day SMA: 1.39 Sell
8-day EMA: 0.64 Sell
20-day EMA: 0.73 Sell
50-day EMA: 0.89 Sell
200-day EMA: 1.33 Sell

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

CEL-SCI Earnings Growth & CVM Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.05 per share, and an increase next year of $0.18 per share.

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CEL-SCI Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):